Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
John Ternus Signals Apple’s Future with Product-First AI Strategy 
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO 
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
WASHINGTON, March 06, 2017 -- Surefire Medical, Inc. today announced the launch of the new Flexion Guiding Catheter at the Society for Interventional Radiology (SIR) meeting in Washington, DC. The device has a main curve reinforced with nitinol to provide better shape retention and back-up support for interventional radiologists performing embolization procedures.
In addition to the differentiated nitinol curve, the Surefire Flexion offers the following features:
- An inner diameter of 0.054 inches with a PTFE liner
- Soft radiopaque tip that facilitates vessel engagement and catheter placement
- Double-stranded steel braid for optimal kink resistance and torque response.
“This is truly an engineering breakthrough,” said James E. Chomas, President and CEO of Surefire Medical. “The nitinol reinforcement enables this device to keep a low 5F profile while providing physicians with maximum support during Surefire procedures, or any other procedures that would require a guide catheter with a large lumen. We are excited to launch this device and continue to demonstrate Surefire’s commitment to the interventional radiology market.”
The Surefire Flexion Guiding Catheter is available in two shapes – the Axis and SIM1. The company continues to offer the Surefire Cobra Guiding Catheter.
About Surefire Medical
Surefire Medical, Inc. develops, manufactures and markets targeted delivery devices for the Interventional Oncology markets. Surefire’s core technology consists of a microcatheter with a unique expandable tip that improves tumor uptake while protecting healthy tissue. It enables physicians to target tumors with superior accuracy, control and protection. Learn more: www.surefiremedical.com.
Media Contact: Jenna Clark Surefire Medical 303.717.2339 [email protected]
